The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Triple-negative breast cancer (TNBC) outcomes with partial breast irradiation and concurrent chemotherapy (PBI-CC) compared with whole breast irradiation and sequential chemotherapy (WBI-SC).
L. M. De Souza Lawrence
No relevant relationships to disclose
A. Shah
No relevant relationships to disclose
V. Stearns
Research Funding - Abraxis BioScience
F. Asrari
No relevant relationships to disclose
D. A. Frassica
No relevant relationships to disclose
T. N. Tsangaris
No relevant relationships to disclose
J. H. Fetting
No relevant relationships to disclose
J. R. Lange
No relevant relationships to disclose
L. K. Jacobs
No relevant relationships to disclose
R. C. Zellars
No relevant relationships to disclose